La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Enveric Biosciences a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Enveric Biosciences..

Enveric Biosciences (NASDAQ:ENVB) Azioni, Catena delle Opzioni

Enveric Biosciences

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

Enveric Biosciences Inc

Billionaire Warren Buffett, who became&nbsp;a millionaire by age 32, shares his secret to success with Gen Z: it&#8217;s not just about hard work, but also about the company you keep.
What Happened: Buffett's journey began with selling Coca-Cola door-to-door, a humble start that helped shape his future success. He believes others can follow his path if they identify their strengths, choose the right people, and aren&#8217;t afraid of making mistakes.
See Also:&nbsp;<a href="https://benzinga.com/markets/equities/25/04/44704005/trumps-104-tariff-on-chinese-imports-sends-stock-futures-plunging-dow-falls-over-500-points" target="_blank" rel="noreferrer noopener">Trump&#8217;s 104% Tariff On Chinese Imports Sends Stock Futures Plunging — Dow Falls Over 500 Points</a>
Buffett, the head of Berkshire Hathaway Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>), in an <a href="https://www.instagram.com/cbssundaymorning/reel/DGqR78rOelc/">interview</a> with CBS News in March, emphasized the importance of surrounding oneself with the right people throughout one&#8217;s career. He highlighted intelligence, energy, and integrity as the top qualities he seeks in a work partner. He warned against trying to change people, citing his successful partnership with the late Charlie Munger as an example.
"Figure out what your strengths are and then pick the right people and don't be afraid of making mistakes," he said.
Buffett also noted that choosing the <a href="https://www.benzinga.com/markets/cryptocurrency/24/03/37988324/sam-bankman-fried-sentenced-to-25-years-judge-points-to-ambition-political-manipulation">wrong business partner can be costly</a>, using the example of Sam Bankman-Fried, whose cryptocurrency exchange went bankrupt. He encouraged Gen Zers to be resilient in the face of adversity and to invest in themselves.
Why It Matters: Buffett&#8217;s advice aligns with his previous statements. In 2024, he advised everyone to &#8220;<a href="https://www.benzinga.com/personal-finance/24/07/40073339/advice-from-warren-buffett-that-everyone-needs-to-hear-write-your-obituary">write your obituary</a>&#8221; and live up to it, reflecting on mortality after the passing of his business partner, Charlie Munger. In March 2025, he emphasized the importance of choosing the right life partner, attributing his success to this decision in a conversation with Bill Gates. 
He also discouraged accepting jobs solely for their resume value or slightly higher starting pay, instead recommending finding work with a person or organization one admires, as reported in a speech at the University of Georgia.
Meanwhile, as President Donald Trump&#8216;s tariff hike rattled global markets, billionaires like Elon Musk, Jeff Bezos, and Mark Zuckerberg saw their fortunes tumble. Meanwhile, the ‘Oracle of Omaha'—Buffett—<a href="https://www.benzinga.com/tech/25/04/44658417/warren-buffett-stands-tall-in-2025-as-elon-musk-jeff-bezos-and-mark-zuckerberg-bleed-billions-in-net-worth-oracle-of-omaha-emerges-as-lone-gainer-among-top-billionaires-amid-market-rout">stood out as the only top 10 billionaire</a> to post a year-to-date net worth gain in 2025.
Read Next:
<ul>
<li>Invest in the future of digital engagement —<a href="https://benzingapartners.go2cloud.org/aff_c?offer_id=559&amp;aff_id=1&amp;tblci=GiDztrPhRgf66i_FsvfOfYo_Yn9p12IB6nL8nUpMGNC31yDvwVook6q8vfDMmLc4MO-ISg" target="_blank" rel="noreferrer noopener"> own a piece of the $100 billion Metaverse for $500</a>.</li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image via Shutterstock

News

Tech

General

Want To Succeed Like Warren Buffett? It Might All Come Down To Who You Surround Yourself With: 'Pick The Right People'

This significant milestone marks the beginning of a critical trial aimed at providing access to MN-166 for ALS patients who are not eligible for the ongoing Phase 2/3 COMBAT-ALS trial. The EAP trial, funded by the National Institutes of Health (NIH) - Neurological Disorders and Stroke (NINDS)1-3, will evaluate the safety and efficacy of MN-166 in approximately 200 ALS patients.

MNOV

Reported Earlier, MediciNova Announces First Enrollment In NIH-Supported EAP Trial To Assess MN-166 In Advanced ALS Patients

Anthony Scaramucci, founder and managing partner of&nbsp;SkyBridge Capital, reflected on his unwavering faith in Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) on Tuesday despite being mocked for it in the past.
What Happened:&nbsp;During an interview with journalist and author Katty Kay, Scaramucci talked about a bobblehead made by his staff, depicting him&nbsp;sinking in a Bitcoin boat.&nbsp;
This was a reference to a picture featured in a New York Post&#8217;s three-year-old <a href="https://nypost.com/2022/07/20/anthony-scaramucci-doubles-down-on-crypto-as-clients-eye-the-exits/">piece </a>about Scaramucci&#8217;s Bitcoin conviction despite pressures faced by his flagship SkyBridge fund. The cartoon showed Scaramucci sinking his Bitcoin-laden boat, labeled &#8220;S.S. Mooch,&#8221; in water.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Trump&#039;s Trillion Dollar Market MELTDOWN" width="500" height="281" src="https://www.youtube.com/embed/11Ccj-fzwbQ?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
See Also:&nbsp;<a href="https://benzinga.com/markets/cryptocurrency/25/04/44664914/bitcoin-ethereum-xrp-dogecoin-obliterate-142-billion-in-liquidations-plummet-up-to-16" target="_blank" rel="noreferrer noopener">Bitcoin, Ethereum, XRP, Dogecoin Obliterate $1.42 Billion In Liquidations, Plummet Up To 16%</a>
That was the time when Bitcoin traded around the $20,000 mark, a sharp drawdown from the all-time highs hit in the 2021 bull market. The SkyBridge fund, which had more than 20% in cryptocurrency-related investments, was hit by surging withdrawals.
&#8220;Just a reminder, I didn&#8217;t&nbsp;sell any Bitcoin there, and&nbsp;I was rewarded,&#8221; Scaramucci said, signaling how Bitcoin has rebounded and even crossed $100,000 since then.
Why It Matters:&nbsp; Scaramucci&#8217;s conviction in Bitcoin has been well-known. Last month, he described Bitcoin as a &#8216;digital store of value&#8217; and a <a href="https://in.benzinga.com/markets/cryptocurrency/25/03/44249696/anthony-scaramucci-says-bitcoin-is-digital-store-of-value-and-the-us-should-own-it">strategic asset that the U.S. should hold in its reserves.</a> He praised the Trump administration&#8217;s efforts to establish a Bitcoin reserve, arguing that it positions the cryptocurrency as a critical component of the nation&#8217;s financial future.&nbsp;
Scaramucci revealed that over<a href="https://in.benzinga.com/25/01/42906639/anthony-scaramucci-was-asked-about-his-take-profit-strategy-on-bitcointhis-is-what-he-said"> 50% of his net wealth</a> is tied up in Bitcoin and that he would not sell his Bitcoin but rather target altcoins such as Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) in the long run.
Price Action:  At the time of writing, Bitcoin was exchanging hands at $76,928.88, down 3.09% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>. Year-to-date, the cryptocurrency has dropped 17.62%.
Image via Shutterstock
Read Next:&nbsp;
<ul>
<li><a href="https://benzinga.com/markets/cryptocurrency/25/04/44696527/forget-dogecoin-shiba-inufartcoin-emerges-as-recession-hedge-with-surging-strength" target="_blank" rel="noreferrer noopener">Forget Dogecoin, Shiba Inu—Fartcoin Emerges As &#8216;Recession Hedge&#8217; With Surging Strength</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" rel="noreferrer noopener" target="_blank"></a>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

$BTC

$SOL

Anthony Scaramucci Rode His BTC Boat Through Choppy Waters Of 2022 Bear Market: 'Didn't Sell Any Bitcoin There, And I Was Rewarded'

Christophe Fouquet, CEO of semiconductor heavyweight ASML, has a blunt response for those seeking a shortcut to the corner office: Stop asking. He believes the question "How do I become CEO?" misses the point entirely.
What Happened: "I see too many young people who come to see me, and they want to be CEO, and they ask me ‘how do we become CEO?' And I try to explain to them in the nicest possible way that this is almost an absurd question," Fouquet told Norges Bank Investment Management CEO Nicolai Tangen on the In Good Company podcast.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Christophe Fouquet - CEO of ASML &#x7C; Podcast &#x7C; In Good Company &#x7C; Norges Bank Investment Management" width="500" height="281" src="https://www.youtube.com/embed/hvQvrLjlJN8?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Instead, he said, aspiring leaders should ask, "What am I going to do tomorrow that really gets me excited, that really brings the best out of me?"
See also: <a href="https://www.benzinga.com/general/social-media/25/04/44705344/ray-dalio-says-dont-make-the-mistake-of-thinking-whats-happening-now-is-due-to-trump-tariffs">Ray Dalio Says Don&#8217;t Make The Mistake Of Thinking What&#8217;s Happening Now Is Due To Trump Tariffs</a>
Fouquet, who never craved the C-Suite in his early years, earned around €3.5 million last year. "Because if you go and do that every day, there may be a chance you become CEO — most probably a bigger chance that you don't—but you will equally end up doing something that brings you joy, energy, and most importantly brings that to the people around you." He encourages students to choose subjects they genuinely enjoy instead of focusing on strategic career paths.
ASML, valued at roughly $230 billion, has skyrocketed in importance. Its lithography machines power advanced semiconductor production for top players like Nvidia, fueling tech's post-pandemic and AI-driven surge.
"I think the first part of your career is about proving yourself, I truly believe that," Fouquet said. "And then you look forward, you say, okay, what's next… what can I do to help and where is the place where I can do something that matters?"
Featured image via Shutterstock
Read next: <a href="https://www.benzinga.com/news/25/04/44705011/steve-eisman-of-big-short-fame-says-no-amount-of-fundamental-research-can-help-navigate-trumps-tariff-war-throw-it-out-of-the-window" target="_blank" rel="noreferrer noopener">Steve Eisman Of ‘Big Short' Fame Says No Amount Of Fundamental Research Can Help Navigate Trump's Tariff War, ‘Throw It Out Of The Window'</a>

Education

Management

Nvidia-Supplier ASML's CEO Wants Young Leaders To Stop Asking Him This 'Absurd' But Common Question And Do This Instead

<ul>
<li>After Aggressively Attempting to Undermine the Nippon Steel Transaction, Ancora Has Flip-Flopped and Claims to Now Support the Deal</li>
<li>New Presidential Memorandum Validates the Unwavering Commitment of U. S. Steel's Board to Finish the Job and Deliver Significant Investment from Nippon Steel – in the Face of Ancora's Wrongheaded Attempt to Undermine U. S. Steel's Pursuit of Revisiting the CFIUS Process</li>
<li>Ancora's "Plan" is Contradictory, Full of Unfounded Assumptions and Mimics Cleveland-Cliffs' Failed Strategy</li>
<li>Urges Stockholders to Vote on the WHITE Proxy Card "FOR" U. S. Steel's 10 Director Nominees TODAY</li>
</ul>

Reported Earlier, U. S. Steel Criticizes Ancora's Unrealistic $75 Per Share Claims, Highlights Strong Support For Nippon Steel Deal

Google named the official AI partner of The Wizard of Oz at Sphere and&nbsp;official AI partner of Sphere
Collaboration between Google and Sphere combines immersive entertainment and cutting-edge technology, similar to how the film's use of Technicolor revolutionized movies nearly 90 years ago

GOOG

SPHR

Reported Earlier, Google Named Official AI Partner For The Wizard of Oz at Sphere, Bringing Generative AI To The World's Most Immersive Visual Experience

Reported Earlier, BlackBerry's QNX  And WeRide Collaborate To Advance Autonomous Driving With QNX-Based ADAS For Software-Defined Vehicles

The recruitment landscape is undergoing a significant shift as Artificial Intelligence (AI) is increasingly being utilized to screen resumes and rank applications.
What Happened: The use of AI-powered tools to screen resumes before they reach recruiters is on the rise, reported <a href="https://edition.cnn.com/2025/04/08/tech/ai-resume-job-hunters/index.html">CNN</a>. This is largely due to the high volume of applications that some job postings attract.48% of hiring managers use AI to screen resumes and applications, according to data from Resume Genius.
The AI recruitment sector is projected to grow at a compound annual rate of 6.1% from 2023 to 2030, as per the Society for Human Resources Management.
AI tools can understand the&nbsp;content of a resume, going beyond just scanning for keywords. This allows for a more holistic view of the candidate, inferring skills rather than relying on specific words. This approach benefits both recruiters and candidates, as it allows applications to be seen&nbsp;in their entirety by the&nbsp;algorithm.
AI is also being used to simplify the hiring process. For instance, LinkedIn, owned by Microsoft Corporation, introduced an AI agent for handling routine HR tasks such as screening applications. The agent, called Hiring Assistant, provides a list of top contenders sourced from applicants or the network&#8217;s profiles. LinkedIn is also working on a tool that allows job seekers to describe their desired role rather than searching for a specific job title.
See Also:&nbsp;<a href="https://benzinga.com/markets/equities/25/04/44704005/trumps-104-tariff-on-chinese-imports-sends-stock-futures-plunging-dow-falls-over-500-points" target="_blank" rel="noreferrer noopener">Trump&#8217;s 104% Tariff On Chinese Imports Sends Stock Futures Plunging — Dow Falls Over 500 Points</a>
However, AI is not without its flaws. It is still prone to bias and can sometimes output false information. Experts stress that while AI can streamline the hiring process, the final decision should always be made by a human.
Why It Matters: The rise of AI in recruitment aligns with the&nbsp;<a href="https://in.benzinga.com/news/global/25/01/43149854/ai-ai-agents-will-create-unprecedented-opportunities-and-profound-risks-world-economic-forum-says">World Economic Forum&#8217;s prediction</a>&nbsp;that AI and AI agents will significantly change the workforce and job market. The report suggested that 41% of employers expect to reduce their workforce size in roles where AI can replicate human work.
Moreover,&nbsp;<a href="https://in.benzinga.com/25/02/43425534/linkedin-and-indeed-are-finally-holding-employers-accountable-new-ai-tools-will-show-job-seekers-their-chances-of-getting-a-response">LinkedIn&#8217;s introduction of AI-powered tools</a>&nbsp;to help job seekers gauge their chances of receiving responses from potential employers is a testament to the growing influence of AI in recruitment.
However, it&#8217;s important to note that AI skills are not the only factor in hiring decisions. As Accenture&#8217;s CEO,<a href="https://in.benzinga.com/personal-finance/25/04/44658480/accenture-boss-julie-sweets-simple-question-determines-who-gets-hired-and-its-not-about-ai-skills"> Julie Sweet</a> highlighted, other factors can also play a crucial role in the hiring process. Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/04/44677995/jim-cramer-says-market-rebound-feels-strange-after-nine-nights-of-losses-things-arent-better-as-stock-futures-surge-over-1" target="_blank" rel="noreferrer noopener">Jim Cramer Says Market Rebound Feels ‘Strange' After Nine Nights Of Losses: ‘Things Aren't Better' As Stock Futures Surge Over 1%</a></li>
</ul>
Image via Shutterstock

AI Is Quietly Reshaping How Companies Screen Resumes — Nearly Half Of Hiring Managers Now Use It

BITF

RIOT

Reported Earlier, Riot Platforms Delivers Waiver And Proxy To Bitfarms, Retains 16.3% Ownership With Limited Voting Rights

Delta Air Lines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) will release its first-quarter financial results before the opening <a href="https://www.benzinga.com/quote/DAL/earnings">bell on Wednesday, April 9</a>.
Analysts expect the Atlanta, Georgia-based company to report quarterly earnings at 39 cents per share, down from 45 cents per share in the year-ago period. Delta Air Lines projects quarterly revenue of $13.46 billion, compared to $13.75 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On March 10, Delta Air Lines cut its first-quarter revenue and profit guidance.
Delta Air Lines shares fell 3.8% to close at $35.88 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/DAL/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Barclays analyst Brandon Oglenski maintained an Overweight rating and cut the price target from $80 to $58 on April 8, 2025. This analyst has an accuracy rate of 60%.</li>
<li>Susquehanna analyst Christopher Stathoulopoulos maintained a Positive rating and slashed the price target from $80 to $50 on April 7, 2025. This analyst has an accuracy rate of 70%.</li>
<li>UBS analyst Thomas Wadewitz downgraded the stock from Buy to Neutral and lowered the price target from $77 to $42 on April 7, 2025. This analyst has an accuracy rate of 69%.</li>
<li>Raymond James analyst Savanthi Syth maintained a Strong Buy rating and cut the price target from $80 to $62 on April 2, 2025. This analyst has an accuracy rate of 64%.</li>
<li>Jefferies analyst Sheila Kahyaoglu downgraded the stock from Buy to Hold and decreased the price target from $85 to $46 on April 1, 2025. This analyst has an accuracy rate of 69%.</li>
</ul>
Considering buying DAL stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="588" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09025244/image-40-1024x588.png" alt="" class="wp-image-863057" style="width:594px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09025244/image-40-1024x588.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09025244/image-40-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09025244/image-40-768x441.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09025244/image-40.png 1077w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44684755/top-3-industrials-stocks-you-may-want-to-dump-this-month">Top 3 Industrials Stocks You May Want To Dump This Month</a> </li>
</ul>
Photo via Shutterstock

Earnings

Price Target

Pre-Market Outlook

Analyst Ratings

Trading Ideas

Top Wall Street Forecasters Revamp Delta Air Lines Price Expectations Ahead Of Q1 Earnings

Ray Dalio, founder of Bridgewater Associates and an influential voice among investors, has delivered a sobering message where he states that United States citizens are not just dealing with trade skirmishes but watching the slow-motion collapse of the global system as we know it.
What Happened: In a detailed public post, Dalio criticized the media and market obsession with President <a href="https://in.benzinga.com/25/04/44698325/trump-tariff-strategy-self-inflicted-market-debacle-says-wedbush-analyst">Trump's tariffs</a>, arguing that they are merely "a symptom, not the cause" of the turmoil. "Don't make the mistake of thinking that what's now happening is mostly about tariffs," he warned.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://t.co/Xpdl8fYoBg">https://t.co/Xpdl8fYoBg</a>
&mdash; Ray Dalio (@RayDalio) <a href="https://twitter.com/RayDalio/status/1909296189473693729?ref_src=twsrc%5Etfw">April 7, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<h3 class="wp-block-heading">What&#8217;s Dalio Talking About?</h3>
Dalio outlines what he sees as five converging crises:
<ul>
<li>Monetary and Economic Breakdown: U.S. debt now exceeds $36 trillion and continues to balloon. Dalio calls the U.S.-China economic relationship an "incongruous&#8221; debtor-creditor addiction cycle, driven by deglobalization and dangerously unsustainable borrowing.</li>
<li>Domestic Political Unraveling: He sees a deepening rift between the far left and far right. "Compromise is now viewed as weakness," he noted, echoing data from Pew Research that shows 85% of Americans believe political conflict is worsening.</li>
<li>Geopolitical Realignment: The old U.S.-led world order is breaking apart. Trump's "America First" strategy, from tariffs to tech bans, signals a shift to a "power-rules approach." Dalio connects this to historical cycles in which emerging powers challenge incumbents — China, in this case, whose GDP (PPP) overtook the U.S. in 2024, per IMF data.</li>
<li>Climate Instability: Floods, droughts, and pandemics are no longer one-off events—they&#8217;re systemic shocks that further erode fragile political and financial systems.</li>
<li>Technological Disruption: AI is accelerating everything — from geopolitical arms races to labor market dislocation. "This is not business as usual," Dalio warned.</li>
</ul>
See also: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44705109/whats-next-for-dogecoin-amid-market-correction-analyst-identifies-this-level-as-key-support-to-watch">What&#8217;s Next For Dogecoin Amid Market Correction? Analyst Identifies This Level As &#8216;Key&#8217; Support To Watch</a>
Why It Matters: Dalio suggests that policymakers stop reacting to headlines and start studying the past. "What's happening now resembles the debt-default cycles of the 1930s and the stagflation chaos of the 1970s," he wrote.
Elsewhere, fellow billionaire investor Bill Ackman, CEO of Pershing Square, warns of severe potential <a href="https://www.benzinga.com/25/04/44659521/bill-ackman-warns-against-launching-economic-nuclear-war-wants-a-90-day-time-out-on-trump-tariffs">economic repercussions</a> of escalating tariffs, stating that business relies heavily on trust and confidence. Ackman also called for a 90-day pause on tariff implementation — a move that was <a href="https://www.benzinga.com/25/04/44680956/billionaire-banker-backs-trumps-shock-and-awe-tariff-policies-slams-bill-ackmans-call-for-90-day-pause">slammed</a> by another billionaire Andrew Beal. Similarly, Jamie Dimon, CEO of JPMorgan Chase &amp; Co. JPM, <a href="https://www.benzinga.com/25/04/44665530/jamie-dimon-once-a-tariff-supporter-warns-trumps-new-policy-could-slow-us-growth-fuel-inflation-the-quicker-the-issue-is-resolved-the-better">cautioned</a> that the tariffs could trigger inflation and slow the U.S. economy.
Featured Image via Bridgewater Associates
Read next: <a href="https://www.benzinga.com/news/25/04/44705011/steve-eisman-of-big-short-fame-says-no-amount-of-fundamental-research-can-help-navigate-trumps-tariff-war-throw-it-out-of-the-window">Steve Eisman Of &#8216;Big Short&#8217; Fame Says No Amount Of Fundamental Research Can Help Navigate Trump&#8217;s Tariff War, &#8216;Throw It Out Of The Window&#8217;</a>

Government

Social Media

Ray Dalio Says Don't Make The Mistake Of Thinking What's Happening Now Is Due To Trump Tariffs

INTJ

Intelligent Joy Limited Partners With CLS Press And Smart IR To Develop Next-Gen AI-Driven Investor Relations Solution

– Clinical and preclinical data supporting dosing profile and tolerability for ABI-5366, a novel long-acting helicase-primase inhibitor candidate, featured in two poster presentations –
– Additional poster presentation highlights new insights in genital herpes prevalence and treatment patterns in the U.S. –
– ABI-5366 is currently being evaluated in ongoing Phase 1b clinical trial with interim proof-of-concept data expected in fall 2025 –

ASMB

Assembly Biosciences Unveils Data On Long-Acting HSV Candidate ABI-5366 And U.S. Genital Herpes Trends At 2025 ESCMID Congress

Fnality's digital representation of funds held at central banks serves as a settlement rail for Broadridge's DLR platform bringing greater efficiency, liquidity and risk reduction to financial markets in both the U.S. and Europe

Broadridge Teams Up with Fnality To Advance DLR Platform With Real-Time Digital Cash Settlement Capability

Common-use&nbsp;ARINC cMUSE&#x2122;&nbsp;solution delivers flexibility, scalability and efficiency to more than 80 airlines at London Heathrow

Collins Aerospace Secures Six-Year Extension With Heathrow AOC To Continue Powering Passenger Processing Across All Terminals

Amid the ongoing slump, an influential cryptocurrency analyst identified a crucial support level for Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) on Tuesday that investors should closely monitor.
What Happened:&nbsp;Ali Martinez, known for identifying chart patterns and issuing price predictions, shared insights on the Dogecoin&#8217;s price action in an X post. 
The analyst noticed that the meme-based cryptocurrency has followed a rising trendline since October 2023. This trendline&nbsp;now converges with the 61.8%&nbsp;Fibonacci retracement level at $0.13, making it a &#8220;key&#8221; support level to keep an eye on.
Fibonacci retracement is a technical analysis tool that uses ratios derived from the Fibonacci sequence to determine probable support and resistance levels. These are then used to predict reversals or continuations.
The 61.8% level, often referred to as the &#8220;golden ratio,&#8221; is particularly significant.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Since October 2023, <a href="https://twitter.com/hashtag/Dogecoin?src=hash&amp;ref_src=twsrc%5Etfw">#Dogecoin</a> <a href="https://twitter.com/search?q=%24DOGE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$DOGE</a> has respected a rising trendline that now converges with the 61.8% Fib retracement at $0.13, making this a key support level to watch. <a href="https://t.co/fSlblEcpiu">pic.twitter.com/fSlblEcpiu</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1909673597784015173?ref_src=twsrc%5Etfw">April 8, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also:&nbsp;<a href="https://benzinga.com/markets/cryptocurrency/25/04/44664914/bitcoin-ethereum-xrp-dogecoin-obliterate-142-billion-in-liquidations-plummet-up-to-16" target="_blank" rel="noreferrer noopener">Bitcoin, Ethereum, XRP, Dogecoin Obliterate $1.42 Billion In Liquidations, Plummet Up To 16%</a>
Why It Matters:&nbsp; Notably, the world&#8217;s largest meme coin has been under considerable selling pressure recently, sliding more than 15% over the week and 17% over the month. 
Speculative interest for the coin has dwindled, with the Open Interest falling over 75% from January highs, <a href="https://www.coinglass.com/BitcoinOpenInterest">according </a>to Coinglass. That said, the Long/Short ratio was over 1, signaling that the number of traders holding long positions was higher than those betting on its price decline.
Meanwhile, the crucial Moving Average Convergence Divergence indicator, which compares two exponential moving averages of an asset&#8217;s price, flashed a &#8220;Sell&#8221; signal for DOGE,&nbsp;<a href="https://in.tradingview.com/symbols/DOGEUSD/technicals/" target="_blank" rel="noreferrer noopener">according</a>&nbsp;to TradingView.
Conversely, Williams Percent Range, another momentum indicator used to ascertain whether an asset is overbought or oversold, signaled &#8220;Buy,&#8221; suggesting that a reversal might be around the corner.
Price Action:  At the time of writing, Dogecoin was exchanging hands at $0.1434, down 4.91% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>. Year-to-date, the cryptocurrency was down 54.48%.
Image via Shutterstock
Read Next:&nbsp;
<ul>
<li><a href="https://benzinga.com/markets/cryptocurrency/25/04/44699720/bitcoin-ethereum-xrp-dogecoin-extend-losses-as-white-house-hammers-chinese-goods-with-104-tariff" target="_blank" rel="noreferrer noopener">Bitcoin, Ethereum, XRP, Dogecoin Extend Losses As White House Hammers Chinese Goods With 104% Tariff &#8211; Benzinga</a></li>
</ul>

$DOGE

What's Next For Dogecoin Amid Market Correction? Analyst Identifies This Level As 'Key' Support To Watch

Shigellosis is the second leading cause of fatal diarrheal disease worldwide, strongly contributing to pediatric morbidity and mortality. It is estimated that up to 165 million infections are due to Shigella of which 62.3 million occur in children younger than five years1. Developing an effective vaccine to prevent this deadly disease is a public health imperative for many areas of the world.
In the Phase 2 study S4V02 (Identifier: <a href="https://www.globenewswire.com/Tracker?data=CMXvjUfpdAwac2StPwswjjvPG-9ZR2meaVCkA_nx007OcjEjTEXQTGdHR75_S1dAzRLqmiHl61lpOF7Hoe8pfF-bRMmNe8yKQqm2heCf2f4cLNX-UWTLFSGUqOEmvIheYS6VikJQEW-HY2QkP5GZd2xUeh2YHaApwvBiS4_2BhnV9uyhpFWEqj_9CBpnl7PW">NCT06523231</a>), the safety and immunogencity of S4V2 will be tested in approximately 110 nine-month-old infants with the goal of identifying the best dose to be tested in a Phase 3 trial. Sponsored and conducted by LimmaTech, S4V02 is a randomized, controlled, and blinded study conducted at a single study site in Kenya. Participants will receive a two-dose vaccination with one of two different vaccine dose levels of S4V2 or a control vaccine. Safety will be evaluated throughout the trial for approximately six months following the last vaccination. Results of the study, which is supported by funding from the Gates Foundation, are expected in the second half of 2025.

VALN

First Infant Vaccinated in Valneva And LimmaTech's Phase 2 S4V2 Trial, Targeting Global Shigellosis Threat

Legendary investor Steve Eisman, whose foresight on subprime mortgages was spotlighted in "The Big Short," has fired off a cautionary salvo for investors looking into the equity market for solutions, declaring that traditional investment analysis has become virtually worthless amid the current trade tensions.
What Happened: In light of President Donald Trump's recent tariff announcements, Eisman, speaking in his new podcast, believes traditional analysis can't keep up: "You can't model it (news flow). There is no other variable that matters. You can do any fundamental work on a company you want… but take it and throw it out the window."
His warning arrives as markets struggle with Trump's "Liberation Day" tariffs, unveiled on April 2, which levied substantial duties on U.S imports. The fallout has jolted investors, sending the VIX Index near five-year highs and overshadowing conventional market metrics. Eisman hosts his podcast with longtime collaborators Danny Moses, Porter Collins, and Vincent Daniel. Together, they argue that policy-heavy fluctuations are overshadowing economic fundamentals.
See also: <a href="https://www.benzinga.com/news/ipos/25/04/44704651/fatpipe-stock-rips-126-on-nasdaq-debut-before-paring-some-gains-after-hours">FatPipe Stock Rips 126% On Nasdaq Debut Before Paring Some Gains After-Hours</a>
In May 2024, Eisman, in a Bloomberg TV interview, called fears of tariff-driven inflation "ridiculous." Now, while not necessarily predicting economic disaster, he appears to be signaling that the traditional tools investors rely on are ineffective in the current climate.
Why It Matters: Wall Street's early surge was reversed on Tuesday as the White House confirmed plans for "massive" <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44698697/markets-reverse-gains-as-trumps-104-china-tariff-announcement-rattles-wall-street">new tariffs on China</a>, jolting the Dow down by <a href="https://in.benzinga.com/markets/equities/25/04/44704005/trumps-104-tariff-on-chinese-imports-sends-stock-futures-plunging-dow-falls-over-500-points">over 500 points</a>. Investors, who initially took solace in bargain valuations and the hope that trade fears might ease, watched the rally collapse once the administration announced it would impose "an additional 84% in levies" starting Wednesday.
"It's finding the bottom now. It's finding the bottom now," said White House trade adviser Peter Navarro, dismissing recession concerns by predicting "Dow 50,000. I guarantee that, and I guarantee no recession." However, major banks such as Goldman Sachs and JPMorgan Chase warn that escalating tariffs <a href="https://www.benzinga.com/25/04/44662991/goldman-sachs-raises-risk-of-recession-to-45-jefferies-calls-tariffs-a-free-hall-pass-for-tech-giants-to-reset-their-goals">may spark</a> a global economic slowdown. Even some Trump allies, including Elon Musk, have <a href="https://in.benzinga.com/markets/equities/25/04/44679026/elon-musk-made-unsucessful-appeals-to-trump-to-reverse-new-tariffs-as-tesla-likely-to-take-a-hit-report">labeled</a> tariffs "bad policy" that rests on "extremely flawed logic."
Cover Image via International Monetary Fund
Read next: <a href="https://www.benzinga.com/25/04/44704472/coal-stocks-rally-as-trump-signs-executive-order-to-revive-industry">Peabody Energy, Core Natural Spike In Rally Stoked By Trump&#8217;s Executive Order Ending &#8216;War On Beautiful, Clean Coal&#8217;</a>

Steve Eisman Of 'Big Short' Fame Says No Amount Of Fundamental Research Can Help Navigate Trump's Tariff War, 'Throw It Out Of The Window'

Taiwan Semiconductor Manufacturing Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) shares fell 3.37% to close at $141.37 on Tuesday, extending losses in after-hours trading by another 1.89% to $138.70, as investors continued to react to President Donald Trump&#8217;s threat of imposing tariffs as high as 100% if the chipmaker did not build manufacturing plants in the U.S.
What Happened: Speaking at a National Republican Committee dinner Tuesday, Trump claimed his aggressive tariff strategy has already secured major U.S. investments without government subsidies. 
&#8220;TSMC, the biggest, most powerful chip maker in the world&#8230; they&#8217;re spending $200 billion in Arizona building one of the biggest plants in the world, and that&#8217;s without money,&#8221; Trump said. &#8220;All I did is say if you don&#8217;t build your plant here, you&#8217;re going to pay a big tax — 25%, maybe 50%, maybe 75%, maybe 100%.&#8221;
&#8220;This is without that stupid CHIPS Act, where they say, &#8216;Here&#8217;s billions of dollars to a company that doesn&#8217;t need it.&#8217; These chip companies are loaded. They give these companies billions of dollars to build a plant in the United States. They don&#8217;t build them in the United States. They keep the money. It looks good.&#8221; Trump said. 
The semiconductor giant&#8217;s stock has been under pressure amid a broader tech selloff, with Taiwan&#8217;s tech-dominated Taiex index down 23.67% year-to-date.
See Also: <a href="https://www.benzinga.com/25/04/44703811/elizabeth-warren-says-congress-has-power-to-pull-our-economy-back-from-the-brink-as-don-bacon-moves-to-limit-trumps-tariff-power-need-a-handful-of-republicans-not-to-bend-a-knee">Elizabeth Warren Says Congress Has &#8216;Power To Pull Our Economy Back&#8217; From The Brink As Don Bacon Moves To Limit Trump&#8217;s Tariff Power: &#8216;Need A Handful Of Republicans Not To Bend A Knee&#8217;</a>
Why It Matters: Analyst Ming-Chi Kuo warned investors to remain cautious about semiconductor stocks given Trump&#8217;s tariff policies, noting that even Apple Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) substantial $500 billion U.S. investment f<a href="https://www.benzinga.com/25/04/44662708/top-analyst-ming-chi-kuo-warns-semiconductor-stocks-face-near-term-risks-under-trump-tariff-policy-even-apples-500-billion-us-investment-didnt-buy-it-leniency">ailed to shield it from tariff considerations</a>.
Despite Trump&#8217;s persistent criticism of the CHIPS Act, calling it a &#8220;horrible thing,&#8221; his administration recently established the United States Investment Accelerator within the Commerce Department to <a href="https://www.benzinga.com/government/regulations/25/04/44584283/days-after-calling-the-chips-act-a-horrible-thing-donald-trump-sets-up-new-entity-for-negotiating-much-better-deals-heres-more">oversee the program</a>, focusing on &#8220;negotiating much better CHIPS Act deals.&#8221;
TSMC, which supplies chips to major tech companies including Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), has committed to <a href="https://in.benzinga.com/markets/25/03/44486436/tsmcs-165-billion-bet-on-us-chip-manufacturing-raises-alarms-in-taiwan-amid-china-threat-experts-warn-taipei-must-plan-beyond-its-silicon-shield">significant manufacturing investments in Arizona</a>. 
These developments come as the company is reportedly finalizing a 20% stake in a joint venture with Intel Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>), which <a href="https://www.benzinga.com/25/04/44640394/tsmc-to-take-20-stake-in-joint-venture-with-intel-amid-us-chipmakers-struggles-with-188-billion-net-loss-in-2024-report">posted an $18.8 billion net loss</a> in 2024.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/personal-finance/25/04/44703064/shaq-says-billionaire-magic-johnson-gave-him-the-best-money-advice-being-famous-is-cool-but-at-some-point-you-want-to-start-owning-things" target="_blank" rel="noreferrer noopener">Shaq Says Billionaire Magic Johnson Gave Him the ‘Best' Money Advice — Being Famous Is Cool, ‘But At Some Point, You Want to Start Owning Things'</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

AAPL

INTC

NVDA

Trump Threatened TSMC He'd Impose Up To 100% Tariffs If It Didn't Manufacture Chips In US: 'These Chip Companies Are Loaded'

Macro Economic Events

Econ #s

Economics

INDA

India Interest Rate Decision 6.00% Vs. 6.00% Est.; 6.25% Prior

Press Releases

Enveric Biosciences Receives Notice of Allowance for Lead Drug Candidate EB-003 from United States Patent and Trademark Office

Enveric Biosciences Announces Pricing of $5 Million Public Offering

Enveric Biosciences Announces Closing of $5 Million Public Offering

Enveric Biosciences and Restoration Biologics Announce Licensing Agreements to Treat Joint Disease

Enveric Biosciences Unveils EVM401 Series of Compounds with New U.S. Patent

Small-Caps Under $2 on the Move: ENVB, ONVO, TRNR, PRSO, PNPN.V Gaining Momentum

Enveric Biosciences CEO Issues Letter to Shareholders

Enveric Biosciences Launches Request-For-Proposals Solicitation Process for PsyAI Trademark

Enveric Biosciences Participating in BIO-Europe Spring®

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2024

ENVB

ONVO

PNPNF

PRSO

TRNR

TSXV:PNPN

Adial Pharmaceuticals, Inc - Common Stock

Adial Pharmaceuticals

Akanda

Artelo Biosciences

CNS Pharma

China Pharma Holding

Evoke Pharma

Eyenovia

Hepion Pharmaceuticals, Inc. - Common Stock

Hepion Pharmaceuticals

Jaguar Health

NovaBay Pharmaceuticals, Inc. Common Stock

NovaBay Pharmaceuticals

Processa Pharmaceuticals, Inc. - Common Stock

Processa Pharmaceuticals

Petros Pharmaceuticals, Inc. - Common Stock

Petros Pharma

Redhill Biopharma Ltd. - American Depositary Shares

Redhill Biopharma

SenesTech

Sonoma Pharmaceuticals, Inc. - Common Stock

Sonoma Pharmaceuticals

60 Degrees Pharmaceuticals, Inc. - Common Stock

60 Degrees

TNF Pharmaceuticals

Titan Pharmaceuticals, Inc. - Common Stock

Comments

Enveric Biosciences

Enveric Biosciences (ENVB) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO